Patient, Doctor, Health System Affect Glaucoma Drop Compliance

Why It Matters

Improving glaucoma medication compliance can reduce preventable vision loss and lower long‑term healthcare costs, making it a critical focus for clinicians and health systems.

Key Takeaways

• Patients miss drops due to routine disruptions and prescription delays
• Clinicians lack time, staff, and educational tools to monitor adherence
• Self‑reported adherence is viewed as unreliable by many eye‑care providers
• Framing adherence as a shared challenge may improve patient‑provider communication
• Study offers theory‑based foundation for targeted glaucoma adherence interventions

Pulse Analysis

Glaucoma remains a leading cause of irreversible blindness worldwide, and effective intra‑ocular pressure (IOP) control hinges on patients consistently using prescribed eye drops. Yet adherence rates hover around 50 % in many populations, driven by factors such as daily routine disruptions, medication shortages, and the physical difficulty of instilling drops. As the global burden of glaucoma rises, health systems are under pressure to address these behavioral barriers, not only to preserve vision but also to curb the escalating costs associated with advanced disease management.

The recent qualitative study from City, St. George’s and collaborators sheds light on the nuanced interplay between patient behavior and clinician constraints. Using the theoretical domains framework, researchers identified 14 behavioral domains influencing adherence, revealing that both patients and practitioners struggle with medication availability, prescription delays, and limited educational support. Notably, eye‑care providers expressed skepticism toward self‑reported adherence, fearing it may mask true non‑compliance. This disconnect underscores the need for structured, non‑judgmental dialogues that normalize adherence challenges and encourage honest disclosure, shifting the narrative from patient failure to a shared responsibility.

For industry stakeholders, the findings point to actionable pathways: invest in digital adherence tools, streamline pharmacy workflows, and develop clinician‑focused training that equips staff to conduct empathetic adherence conversations. Theory‑informed interventions—such as habit‑forming reminders or community‑based support programs—can be tailored to address identified barriers. By integrating these strategies, health systems can improve clinical outcomes, enhance patient satisfaction, and ultimately reduce the economic toll of preventable vision loss in glaucoma care.